Systemic targeting of lymph node metastasis through the blood vascular system by using size-controlled nanocarriers

Horacio Cabral, Jun Makino, Yu Matsumoto, Peng Mi, Hailiang Wu, Takahiro Nomoto, Kazuko Toh, Naoki Yamada, Yuriko Higuchi, Satoshi Konishi, Mitsunobu Kano, Hiroshi Nishihara, Yutaka Miura, Nobuhiro Nishiyama, Kazunori Kataoka

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Occult nodal metastases increase the risk of cancer recurrence, demoting prognosis and quality of life of patients. While targeted drug delivery by using systemically administered nanocarriers can potentially control metastatic disease, lymph node metastases have been mainly dealt by locally injecting nanocarriers, which may not always be applicable. Herein, we demonstrated that sub-50 nm polymeric micelles incorporating platinum anticancer drugs could target lymph node metastases in a syngeneic melanoma model after systemic injection, even after removing the primary tumors, limiting the growth of the metastases. By comparing these micelles with clinically used doxorubicin-loaded liposomes (Doxil) having 80 nm, as well as a 70 nm version of the micelles, we found that the targeting efficiency of the nanocarriers against lymph node metastases was associated with their size-regulated abilities to extravasate from the blood vasculature in metastases and to penetrate within the metastatic mass. These findings indicate the potential of sub-50 nm polymeric micelles for developing effective conservative treatments against lymph node metastasis capable of reducing relapse and improving survival.

Original languageEnglish
Pages (from-to)4957-4967
Number of pages11
JournalACS Nano
Volume9
Issue number5
DOIs
Publication statusPublished - May 26 2015

Fingerprint

cardiovascular system
lymphatic system
Micelles
metastasis
blood
Blood
micelles
Disease control
Liposomes
Platinum
Doxorubicin
drugs
Tumors
prognosis
delivery
Pharmaceutical Preparations
platinum
tumors
cancer
injection

Keywords

  • Doxil
  • intravital microscopy
  • lymph node metastasis
  • melanoma
  • oxaliplatin
  • polymeric micelles

ASJC Scopus subject areas

  • Engineering(all)
  • Materials Science(all)
  • Physics and Astronomy(all)

Cite this

Cabral, H., Makino, J., Matsumoto, Y., Mi, P., Wu, H., Nomoto, T., ... Kataoka, K. (2015). Systemic targeting of lymph node metastasis through the blood vascular system by using size-controlled nanocarriers. ACS Nano, 9(5), 4957-4967. https://doi.org/10.1021/nn5070259

Systemic targeting of lymph node metastasis through the blood vascular system by using size-controlled nanocarriers. / Cabral, Horacio; Makino, Jun; Matsumoto, Yu; Mi, Peng; Wu, Hailiang; Nomoto, Takahiro; Toh, Kazuko; Yamada, Naoki; Higuchi, Yuriko; Konishi, Satoshi; Kano, Mitsunobu; Nishihara, Hiroshi; Miura, Yutaka; Nishiyama, Nobuhiro; Kataoka, Kazunori.

In: ACS Nano, Vol. 9, No. 5, 26.05.2015, p. 4957-4967.

Research output: Contribution to journalArticle

Cabral, H, Makino, J, Matsumoto, Y, Mi, P, Wu, H, Nomoto, T, Toh, K, Yamada, N, Higuchi, Y, Konishi, S, Kano, M, Nishihara, H, Miura, Y, Nishiyama, N & Kataoka, K 2015, 'Systemic targeting of lymph node metastasis through the blood vascular system by using size-controlled nanocarriers', ACS Nano, vol. 9, no. 5, pp. 4957-4967. https://doi.org/10.1021/nn5070259
Cabral, Horacio ; Makino, Jun ; Matsumoto, Yu ; Mi, Peng ; Wu, Hailiang ; Nomoto, Takahiro ; Toh, Kazuko ; Yamada, Naoki ; Higuchi, Yuriko ; Konishi, Satoshi ; Kano, Mitsunobu ; Nishihara, Hiroshi ; Miura, Yutaka ; Nishiyama, Nobuhiro ; Kataoka, Kazunori. / Systemic targeting of lymph node metastasis through the blood vascular system by using size-controlled nanocarriers. In: ACS Nano. 2015 ; Vol. 9, No. 5. pp. 4957-4967.
@article{735edafe89b04e62bc052b539db6d93f,
title = "Systemic targeting of lymph node metastasis through the blood vascular system by using size-controlled nanocarriers",
abstract = "Occult nodal metastases increase the risk of cancer recurrence, demoting prognosis and quality of life of patients. While targeted drug delivery by using systemically administered nanocarriers can potentially control metastatic disease, lymph node metastases have been mainly dealt by locally injecting nanocarriers, which may not always be applicable. Herein, we demonstrated that sub-50 nm polymeric micelles incorporating platinum anticancer drugs could target lymph node metastases in a syngeneic melanoma model after systemic injection, even after removing the primary tumors, limiting the growth of the metastases. By comparing these micelles with clinically used doxorubicin-loaded liposomes (Doxil) having 80 nm, as well as a 70 nm version of the micelles, we found that the targeting efficiency of the nanocarriers against lymph node metastases was associated with their size-regulated abilities to extravasate from the blood vasculature in metastases and to penetrate within the metastatic mass. These findings indicate the potential of sub-50 nm polymeric micelles for developing effective conservative treatments against lymph node metastasis capable of reducing relapse and improving survival.",
keywords = "Doxil, intravital microscopy, lymph node metastasis, melanoma, oxaliplatin, polymeric micelles",
author = "Horacio Cabral and Jun Makino and Yu Matsumoto and Peng Mi and Hailiang Wu and Takahiro Nomoto and Kazuko Toh and Naoki Yamada and Yuriko Higuchi and Satoshi Konishi and Mitsunobu Kano and Hiroshi Nishihara and Yutaka Miura and Nobuhiro Nishiyama and Kazunori Kataoka",
year = "2015",
month = "5",
day = "26",
doi = "10.1021/nn5070259",
language = "English",
volume = "9",
pages = "4957--4967",
journal = "ACS Nano",
issn = "1936-0851",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - Systemic targeting of lymph node metastasis through the blood vascular system by using size-controlled nanocarriers

AU - Cabral, Horacio

AU - Makino, Jun

AU - Matsumoto, Yu

AU - Mi, Peng

AU - Wu, Hailiang

AU - Nomoto, Takahiro

AU - Toh, Kazuko

AU - Yamada, Naoki

AU - Higuchi, Yuriko

AU - Konishi, Satoshi

AU - Kano, Mitsunobu

AU - Nishihara, Hiroshi

AU - Miura, Yutaka

AU - Nishiyama, Nobuhiro

AU - Kataoka, Kazunori

PY - 2015/5/26

Y1 - 2015/5/26

N2 - Occult nodal metastases increase the risk of cancer recurrence, demoting prognosis and quality of life of patients. While targeted drug delivery by using systemically administered nanocarriers can potentially control metastatic disease, lymph node metastases have been mainly dealt by locally injecting nanocarriers, which may not always be applicable. Herein, we demonstrated that sub-50 nm polymeric micelles incorporating platinum anticancer drugs could target lymph node metastases in a syngeneic melanoma model after systemic injection, even after removing the primary tumors, limiting the growth of the metastases. By comparing these micelles with clinically used doxorubicin-loaded liposomes (Doxil) having 80 nm, as well as a 70 nm version of the micelles, we found that the targeting efficiency of the nanocarriers against lymph node metastases was associated with their size-regulated abilities to extravasate from the blood vasculature in metastases and to penetrate within the metastatic mass. These findings indicate the potential of sub-50 nm polymeric micelles for developing effective conservative treatments against lymph node metastasis capable of reducing relapse and improving survival.

AB - Occult nodal metastases increase the risk of cancer recurrence, demoting prognosis and quality of life of patients. While targeted drug delivery by using systemically administered nanocarriers can potentially control metastatic disease, lymph node metastases have been mainly dealt by locally injecting nanocarriers, which may not always be applicable. Herein, we demonstrated that sub-50 nm polymeric micelles incorporating platinum anticancer drugs could target lymph node metastases in a syngeneic melanoma model after systemic injection, even after removing the primary tumors, limiting the growth of the metastases. By comparing these micelles with clinically used doxorubicin-loaded liposomes (Doxil) having 80 nm, as well as a 70 nm version of the micelles, we found that the targeting efficiency of the nanocarriers against lymph node metastases was associated with their size-regulated abilities to extravasate from the blood vasculature in metastases and to penetrate within the metastatic mass. These findings indicate the potential of sub-50 nm polymeric micelles for developing effective conservative treatments against lymph node metastasis capable of reducing relapse and improving survival.

KW - Doxil

KW - intravital microscopy

KW - lymph node metastasis

KW - melanoma

KW - oxaliplatin

KW - polymeric micelles

UR - http://www.scopus.com/inward/record.url?scp=84930655405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930655405&partnerID=8YFLogxK

U2 - 10.1021/nn5070259

DO - 10.1021/nn5070259

M3 - Article

VL - 9

SP - 4957

EP - 4967

JO - ACS Nano

JF - ACS Nano

SN - 1936-0851

IS - 5

ER -